Australia is internationally recognised for the quality of its scientific and medical research. Our shores are host to a highly trained and experienced clinical workforce, backed by state-of-the-art facilities across in-vitro, treatment and analytical domains. As an ICH region with mandatory adherence to Good Clinical Practice and with a clinical environment broadly similar to those of the US, UK and much of Europe, Australian clinical trial data are generally accepted by the major regulators worldwide including the FDA and EMA. Our multicultural society provides immense capacity to meet a broad range of recruitment needs.
Australia’s highly efficient ethics and regulatory framework can substantially reduce both the time and cost associated with the preparation of extensive regulatory applications. The predominance of clinical trials in Australia fall under the remit of the Clinical Trial Notification scheme, within which a review cycle can typically be completed within 4-8 weeks, allowing you to begin you trial significantly sooner.
Australia has generous tax incentives in place to encourage investment in Research and Development. Companies with an aggregated annual turnover of less than A$20 million receive a 45% refundable tax offset and all other eligible companies receive a 40% non-refundable tax offset. International businesses are not required to hold intellectual property in Australia and clinical trials can be considered as eligible R&D activities.
Australia’s geographic location offers a number of advantages to Companies operating out of the Northern hemisphere. Its opposing seasons afford the distinct advantage of being able to extend trial duration in clime or seasonally sensitive interventions.
My Medical Department’s location in Australia, coupled with our extensive professional networking expertise perfectly positions us to facilitate communications and develop relationships between your company and the region’ Key Opinion Leaders. Possessing significant experience across a broad spectrum of industry, My Medical Department is the ideal choice to act as your operational and communications hub for activities in the APAC region.
Across our team, we have over 20 years of experience with Australia’s clinical trial environment and can provide local insights into both the broad epidemiology and therapeutic landscape of the region.
We offer a diverse array of services ranging from assistance with regulatory and ethics approval, to recruitment, medical monitoring and more in order to facilitate your access to the Australian research environment.
How You Benefit from The Australian Advantage with My Medical Department:
- Globally acclaimed research community
- Highly efficient, expedient and cost-effective ethics and regulatory pathway
- Generous tax incentives for investing in Australian R&D
- Clinical practice in many ways mirrors key global healthcare systems
- Diverse, multicultural society offers broad capabilities for trial recruitment
- Geographical location enables extension of trial duration for seasonal interventions (e.g. influenza vaccines)
- Internationally renowned for excellence in scientific and medical research
- Highly experienced research fraternity working in state-of-the-art laboratories
- ICH region ensures quality of Australian clinical trials, with results accepted by numerous key global regulatory bodies
My Medical Department’s multidisciplinary team have significant experience with Australia’s clinical trial environment, including regulatory and ethics approval, recruitment, medical monitoring and more. With more than 20 years of collective experience of Australia’s clinical trials experience, we offer unique local insights into the broad epidemiology and therapeutic landscape of the region.
My Medical department’s location, coupled with our years of networking expertise perfectly situates us to facilitate communications with your company and the region’s Key Opinion Leaders and to act as a communications hub for your activities across Asia and the Pacific.